Bliss Gvs Pharma Q3 Results

  • BSE: 506197
  • NSE: BLISSGVS
  • ISIN: INE416D01022
  • Sector: Biotechnology & Drugs
BSE
132.250.75 (0.57%)
Volume36.39 K
Updated: Mon 25 Nov, 2024 | 15:28:00
NSE
132.420.87 (0.66%)
Volume8.33 L
Updated: Mon 25 Nov, 2024 | 15:44:17
Today: 132.10
138.20
52-Wk: 92.25
148.95

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Bliss Gvs Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 200.72211.88-%205.72-%
    Selling/ General/ Admin Expenses Total 24.2923.26-%22.14-%
    Depreciation/ Amortization 6.956.39-%4.64-%
    Other Operating Expenses Total 30.2534.51-%34.50-%
    Total Operating Expense 163.98163.90-%162.67-%
    Operating Income 36.7447.98-%43.05-%
    Net Income Before Taxes 40.0459.13-%47.43-%
    Net Income 27.6142.31-%27.94-%
    Diluted Normalized EPS 2.603.98-%2.64-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts